Health Care & Life Sciences » Biotechnology | Sangui Biotech International Inc.

Sangui Biotech International Inc. | Cash Flow

Fiscal year is July-June. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,491.20
1,158.90
634.00
402.40
302.40
181
Depreciation, Depletion & Amortization
0.70
0.30
-
-
-
-
Other Funds
822.90
661.80
46.80
64.90
11.70
0.10
Funds from Operations
667.70
496.80
587.20
337.50
290.60
180.90
Changes in Working Capital
16.80
63.80
83.70
18.30
5.80
31.90
Net Operating Cash Flow
650.80
560.60
503.50
355.90
296.40
212.80
Purchase/Sale of Investments
-
178.00
-
6.30
-
Net Investing Cash Flow
681.30
173.00
25.10
6.30
-
Issuance/Reduction of Debt, Net
-
13.90
118.30
23.70
-
Net Financing Cash Flow
1,057.30
681.40
385.40
386.60
282.20
Net Change in Cash
147.70
37.20
67.30
47.20
12.00
Free Cash Flow
650.90
560.60
503.50
355.90
296.40
Other Sources
23.20
5.00
25.10
-
-
Change in Capital Stock
1,057.30
695.30
267.10
410.30
282.20
Exchange Rate Effect
127.10
89.40
25.70
10.20
2.20
Other Uses
704.50
-
-
-
-

About Sangui Biotech International

View Profile
Address
Alfred Herrhausen Street 44
Witten Nordrhein-Westfalen 58455
Germany
Employees -
Website http://www.sanguibiotech.com
Updated 07/08/2019
Sangui Biotech International, Inc. is a holding company to its subsidiaries which has a purpose of securing financial and access to the capital markets. It engages in the manufacture of wound treatment and cosmetic products as well as licensing partners in doing the same business. The company was founded in 1995 and is headquartered in Witten, Germany.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.